Physician profile
Heather Williamson
NPI 1437938842
$2,126.25
in general payments reported to CMS, 2019-2025
20 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.98 · 2023: $122 · 2024: $827 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,111.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $484.33 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $392.18 | 2024-2025 | |
| Corcept Therapeutics | $318.00 | 2024-2025 | Korlym |
| Novo Nordisk INC | $167.95 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $150.50 | 2025 | Caplyta |
| Lilly USA, LLC | $121.24 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $91.47 | 2024-2025 | Airsupra, Breztri |
| Novartis Pharmaceuticals Corporation | $56.36 | 2024-2025 | |
| Abiomed | $49.38 | 2024-2025 | Impella |
| Lundbeck LLC | $47.12 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $45.47 | 2024 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $35.63 | 2024 | Repatha, Otezla, Evenity |
| Axsome Therapeutics, INC. | $29.38 | 2023 | Sunosi |
| Dexcom, INC. | $28.67 | 2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $21.89 | 2025 | Omnipod |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.57 | 2024 | Austedo Xr |
| Exact Sciences Corporation | $17.89 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $17.88 | 2025 | Trintellix |
| Astellas Pharma US INC | $16.96 | 2024 | Veozah |
| Pfizer INC. | $15.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.